AU2006292154A1 - Combination S-nitrosothiol-based pharmaceutical products for restoring normal breathing rhythm - Google Patents

Combination S-nitrosothiol-based pharmaceutical products for restoring normal breathing rhythm Download PDF

Info

Publication number
AU2006292154A1
AU2006292154A1 AU2006292154A AU2006292154A AU2006292154A1 AU 2006292154 A1 AU2006292154 A1 AU 2006292154A1 AU 2006292154 A AU2006292154 A AU 2006292154A AU 2006292154 A AU2006292154 A AU 2006292154A AU 2006292154 A1 AU2006292154 A1 AU 2006292154A1
Authority
AU
Australia
Prior art keywords
compound
composition
nitrosothiol
breathing
therapeutic composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2006292154A
Other languages
English (en)
Inventor
James C. Mannion
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galleon Pharmaceuticals Inc
Original Assignee
Galleon Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galleon Pharmaceuticals Inc filed Critical Galleon Pharmaceuticals Inc
Publication of AU2006292154A1 publication Critical patent/AU2006292154A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2006292154A 2005-09-20 2006-09-20 Combination S-nitrosothiol-based pharmaceutical products for restoring normal breathing rhythm Abandoned AU2006292154A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US71877205P 2005-09-20 2005-09-20
US60/718,772 2005-09-20
PCT/US2006/036846 WO2007035879A2 (en) 2005-09-20 2006-09-20 Combination s-nitrosothiol-based pharmaceutical products for restoring normal breathing rhythm

Publications (1)

Publication Number Publication Date
AU2006292154A1 true AU2006292154A1 (en) 2007-03-29

Family

ID=37889538

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2006292154A Abandoned AU2006292154A1 (en) 2005-09-20 2006-09-20 Combination S-nitrosothiol-based pharmaceutical products for restoring normal breathing rhythm

Country Status (9)

Country Link
US (1) US20100035998A1 (cg-RX-API-DMAC10.html)
EP (1) EP1940369A4 (cg-RX-API-DMAC10.html)
JP (1) JP2009508965A (cg-RX-API-DMAC10.html)
KR (1) KR20080059229A (cg-RX-API-DMAC10.html)
CN (1) CN101291660A (cg-RX-API-DMAC10.html)
AU (1) AU2006292154A1 (cg-RX-API-DMAC10.html)
BR (1) BRPI0616144A2 (cg-RX-API-DMAC10.html)
CA (1) CA2623184A1 (cg-RX-API-DMAC10.html)
WO (1) WO2007035879A2 (cg-RX-API-DMAC10.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7073501B2 (en) * 1999-02-04 2006-07-11 Univerity Technologies International Inc. Ventilatory stabilization technology
CN101765401B (zh) * 2007-07-26 2013-09-25 优特埃合伙有限公司 用于调整患者呼吸的瞬时介入
CN101888870B (zh) * 2007-10-26 2013-11-27 优特埃合伙有限公司 换气稳定系统
WO2009151744A1 (en) * 2008-04-02 2009-12-17 Galleon Pharmaceuticals, Inc. S-nitrosomercapto compounds and related derivatives
DE102010030096A1 (de) * 2010-06-15 2011-12-15 Wacker Chemie Ag Silanvernetzende Zusammensetzungen
US20120101073A1 (en) * 2010-10-22 2012-04-26 Galleon Pharmaceutical, Inc. Novel Method For Treating Breathing Disorders or Diseases
WO2025207125A1 (en) * 2024-03-26 2025-10-02 The Regents Of The University Of California Combination pharmacological interventions for obstructive sleep apnea

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5380758A (en) * 1991-03-29 1995-01-10 Brigham And Women's Hospital S-nitrosothiols as smooth muscle relaxants and therapeutic uses thereof
ZA963590B (en) * 1995-05-10 1996-11-19 Adcock Ingram Ltd Pharmaceutical composition
JP2003523958A (ja) * 1999-12-23 2003-08-12 ニトロメド インコーポレーテッド ニトロソ化およびニトロシル化されたシクロオキシゲナーゼ−２の阻害剤、組成物ならびに使用法
US20020183366A1 (en) * 2001-03-23 2002-12-05 Garvey David S. Cyclooxygenase-2 inhibitors, compositions and methods of use
US7432301B2 (en) * 2001-08-20 2008-10-07 University Of Virginia Patent Foundation Use of S-nitrosothiol signaling to treat disordered control of breathing

Also Published As

Publication number Publication date
CN101291660A (zh) 2008-10-22
WO2007035879A2 (en) 2007-03-29
KR20080059229A (ko) 2008-06-26
JP2009508965A (ja) 2009-03-05
CA2623184A1 (en) 2007-03-29
EP1940369A2 (en) 2008-07-09
EP1940369A4 (en) 2011-01-26
BRPI0616144A2 (pt) 2013-02-19
US20100035998A1 (en) 2010-02-11
WO2007035879A3 (en) 2007-10-25

Similar Documents

Publication Publication Date Title
JP6931019B2 (ja) 多発性硬化症を処置するためのｓ１ｐ受容体モジュレーター
US11628186B2 (en) Method and composition for the reduction of viral replication, duration and spread of the COVID-19 and the flu
US20120101073A1 (en) Novel Method For Treating Breathing Disorders or Diseases
US20120270848A1 (en) Novel Compositions and Therapeutic Methods Using Same
US20220160655A1 (en) Anxiolytic composition, formulation and method of use
KR101676454B1 (ko) 약물 조합 및 기침 질환의 치료 용도
US20120316189A1 (en) Methods and compositions for reducing the risk associated with the administration of opioid analgesics in patients diagnosed or undiagnosed respiratory illness
US20060034872A1 (en) Compositions and methods for preventing abuse of orally administered medications
WO2012166909A1 (en) Compositions and methods for treating breathing control disorders or diseases
WO2017031319A1 (en) Noradrenergic drug treatment of obstructive sleep apnea
AU1217697A (en) Method of treating and diagnosing sleep disordered breathing and means for carrying out the method
JP2009517393A (ja) 不安症の治療方法
JP2003176240A (ja) ニコチン性アセチルコリン受容体作用薬により関節の潤滑を高める方法
WO2013173317A1 (en) TREATMENT OF OBSTRUCTIVE SLEEP APNEA WITH α2-ADRENERGIC RECEPTOR AGONISTS
JP2003523384A (ja) 睡眠時呼吸障害を治療及び診断する方法並びにその方法を実施する手段
US20100035998A1 (en) Combination s-nitrosothiol pharmaceutical products for restoring normal breathing rhythms
US20100105685A1 (en) S-Nitrosothiol Compounds and Related Derivatives
WO2008151092A1 (en) Methods and compositions for administration of oxybutynin
MX2008003935A (en) Combination s-nitrosothiol-based pharmaceutical products for restoring normal breathing rhythm
US20200069618A1 (en) Compositions having an agent and an enhancer thereof, methods of use, and delivery systems
WO2025054536A1 (en) Cannabinoid delivery
WO2025207484A1 (en) Use of aprepitant and cyclic dipeptide for weight control
WO2008106738A1 (en) Compositions for the treatment of sexual dysfunction

Legal Events

Date Code Title Description
MK3 Application lapsed section 142(2)(c) - examination deferred under section 46 no request for examination